Vol. 9, Special Issue 1, Part L (2025)

The current study was undertaken to evaluate different therapeutic approach for pregnancy toxaemia (PT) in goats. The does after three and half months of gestation having blood β-hydroxybutyric acid (BHBA) levels ≥ 0.8 mmol/L were randomly divided into three groups. Does in Group 1 (n=7) were daily administered with 20 ml of E-Booster (p.o), Group 2 (n=6) were given daily supplementation of 100 gm commercial goat feed and does in Group 3 (n=6) does not receive any treatment or supplementation and served as control. There was a significant decline in mean blood BHBA levels noticed in the treatment groups (Group 1 and Group 2). During the course of therapy, the mean blood glucose level was not varied significantly among the groups. The decrease was almost similar in both the group supplemented with E-Booster and goat feed i.e. reached physiological levels in 3 days of treatment. However, the decline in BHBA was little quicker and sharper in does treated with E-Booster compared to the does supplemented with energy rich goat feed.